Fiona Nicolson, Bristows LLP
Fiona joined Bristows as a partner in 2009 and is based in London. (Bristows is a UK headquartered international law firm, which advises IP rich clients). She is an IP transactional lawyer with many years’ experience in working with a large range of clients across a number of sectors including life sciences, IT, software, engineering, consumer products and academia. In addition to advising blue chip companies and public bodies, Fiona advises growing SMEs, assisting them to enter new markets through licensing and other collaborative ventures. read more
Stasia Ogden, Tmunity Therapeutics, Inc.
Stasia Ogden is the Vice President, Intellectual Property for Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on next-generation T cell immunotherapy. Prior to joining Tmunity, Stasia served as Vice President, Global Patent Litigation Governance for GlaxoSmithKline. She has over two decades of intellectual property and business experience at Baxter, Becton, Dickinson and Company, Motorola, Inc., Monsanto Company and Johnson & Johnson. read more
Dan Quirk, Microsoft
Dan is a Director within Microsoft’s Enterprise Chief Technology Office, where he collaborates with enterprise-class customers to help them build first-movers advantage, shape their future, and digitally transform their businesses via pre-release access to emerging technologies. Before that, he served as the Director of Intellectual Property for Microsoft's Professional Services division, managing contract negotiations for non-standard and complex intellectual property transactions worldwide. read more
Jeremy Schieler, AbbVie Inc.
Jeremy Schieler is a Senior Manager in Technology Licensing and Collaborations at AbbVie Inc. where he is responsible for managing and negotiating IP-related transactions across AbbVie's R&D pipeline. Prior to AbbVie Jeremy worked at The Coca-Cola Company as an IP Strategist in Ingredient Research where he negotiated external research and development agreements and developed IP strategy for The Coca-Cola Company Ingredient Research team. Prior to this, Jeremy spent nearly 10 years in technology commercialization at Community Health Network (Director, Commercialization) and Indiana University Research and Technology Corporation where he most recently served as Director of Technology Commercialization. read more
Julie Watson, Marshall Gerstein & Borun LLP
Julie M. Watson is a patent attorney and member of the transactions practice group at Marshall Gerstein & Borun, LLP, a Chicago-based intellectual property law firm. A licensing professional with deep experience in structuring and negotiating deals to deliver strategic solutions, Julie concentrates her practice on intellectual property transactions with a particular emphasis in technology startups and university technology transfer. Her prior work includes managing nonprofit intellectual property licensing programs including the Wake Forest Institute for Regenerative Medicine and the American Medical Association. read more
Jeffrey Whittle, Womble Bond Dickinson LLP
Jeff Whittle provides over two decades of legal experience to clients in the energy and high-tech industries. He advises on strategic and complex technology transactions, licensing, patent protection, portfolio analysis, and other contentious and transactional intellectual property matters including inter partes reexaminations, post-grant reviews, and derivation proceedings, among other disputed cases.
Jeff has been recognized by Chambers USA, Best Lawyers in America, and The Legal 500 United States, among others, for his outstanding career and contributions to law and intellectual property. read more
View past CLP Chairs here.
Interested in Serving on the Board of Governors?
Contact CLP at email@example.com for more information.
CLP Organizational Chart
Click here to view the CLP organizational chart.